Omeros Corporation's stock surges as narsoplimab data shows 68% lower death risk in HSCT-TMA patients. Click to learn about the potential and risks of OMER stock.

Olly Murs has had to cancel one of his performances due to being advised to rest following a throat infection. The show, ...

Graphic designer, art director, record producer, advertiser, and photographer: Gianni Sassi revolutionised the relationship ...

Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...

Russia views Pakistan as a promising regional partner, with plans for cooperation in both security and trade already underway Read Full Artic ...

OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formation of subsidiary OS Drug Conjugates (OSDC) ...

Cambium Bio (ASX:CMB) has flagged approval from the U.S. FDA for phase three of a clinical trial using its Elate Ocular ...

Mr. Chone Sophonpanich, President and Chief Executive Officer of Bangkok Life Assurance Public Company Limited, revealed that ...

Despite the loss, Daisy Lubbers had a strong night on the court, with 11 points and 12 rebounds. She was followed by Wingo ...

Three and half years of IAG’s rule in Kabul is marked with nothing but chaos, instability, infighting between different groups, strained relations with neighbours and last but not least, its failure ...

A collection of experts on place management, active travel and the future of towns are to speak in Shrewsbury at the end of ...